Otolaryngologic Manifestation and Long-Term Outcome in Mild COVID-19: Experience from a Tertiary Care Centre in India
- PDF / 547,362 Bytes
- 6 Pages / 595.276 x 790.866 pts Page_size
- 79 Downloads / 212 Views
ORIGINAL ARTICLE
Otolaryngologic Manifestation and Long-Term Outcome in Mild COVID-19: Experience from a Tertiary Care Centre in India Smriti Panda1 • Adil Mohamed1 • Kapil Sikka1 • Anupam Kanodia1 • Pirabu Sakthivel1 • Alok Thakar1 • Sushma Bhatnagar2 • Anant Mohan3 Ved Prakash Meena4 • Pavan Tiwari3 • Biswajeet Sahoo5 • Lalit Dar5 • Saurabh Vig2 • Rohit Garg4 • Chitresh Kumar6
•
Received: 1 September 2020 / Accepted: 7 October 2020 Ó Association of Otolaryngologists of India 2020
Abstract This study endeavours to comprehensively the study the spectrum of ENT manifestations in mild and asymptomatic COVID-19 and observe the natural course of anosmia and dysgeusia consequent to SARS-Cov-2 infection. A prospective cohort study was undertaken at a tertiary care centre in India on admitted patients with RT-PCR proven COVID-19. Patients were included provided the baseline National Early Warning Score (NEWS) was less than 4. Patients were screened for ENT manifestations using a questionnaire at baseline, 7 days, 14 days and 28 days. 225 patients were included in the study. Of these complete data at 4 weeks was available for 210. Out of 145 patients with mild COVID-19 (asymptomatic = 80), ENT manifestations accounted for 66.2% of all symptoms. Smell and taste disturbance had an overall incidence of 20% and 45% of ENT manifestations. Temporal trends of the recovery rate of anosmia and dysgeusia were 53.6%
& Kapil Sikka [email protected] 1
Department of Otorhinolaryngology and Head and Neck Surgery, Teaching Block 4th Floor, All India Institute of Medical Sciences, New Delhi, Ansar Nagar East, New Delhi 110029, India
2
Department of Oncoanesthesia, All India Institute of Medical Sciences, New Delhi, New Delhi, India
3
Department of Pulmonary Medicine, All India Institute of Medical Sciences, New Delhi, New Delhi, India
4
Department of Medicine, All India Institute of Medical Sciences, New Delhi, New Delhi, India
5
Department of Microbiology, All India Institute of Medical Sciences, New Delhi, New Delhi, India
6
Department of Surgical Oncology, All India Institute of Medical Sciences, New Delhi, New Delhi, India
and 66.7% at 2 weeks, respectively. Corresponding rates at 3 weeks were 89.29% and 86.7%, respectively. By the end of 4 weeks 96% of the patients had recovered completely. The incidence of anosmia and dysgeusia in this study parallels the rates reported from other Asian countries, albeit, lower than the rates quoted from the Western Hemisphere. We recommend structured reporting of all ENT manifestations especially smell and taste disturbances to accurately identify individuals infected with SARSCov-2. Keywords COVID-19 SARS-Cov-2 Anosmia Dysgeusia ENT Otorhinolaryngology
Introduction The COVID-19 pandemic which began in December 2019 at the Hubei province in China has amounted to 21 million cases and claimed 7 lakh lives worldwide at the time of writing this manuscript [1]. The Indian subcontinent currently accounts for 6 lakh active cases and a total of 50,000 deaths. There has been a
Data Loading...
